Lipoic acid

Quick links to important sections

Lipoic acid

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lipoic acid

Property Description
Active ingredient Thioctic acid (α-Lipoic acid)
Form Tablet, Capsule, Solution for injection
Pharmacological class Metabolic agent, Vitamin-like substance
General Role Antioxidant and Cofactor in energy metabolism
Origin Endogenous substance (natural) and Synthetic (pharmaceutical)

What is Lipoic Acid and How is it Classified?

Lipoic acid, known by its chemical name and International Nonproprietary Name (INN) Thioctic acid, is a unique, essential metabolic agent that functions as an endogenous substance within the human body. This compound is broadly classified as a vitamin-like substance because of its required role as a cofactor for specific mitochondrial enzyme complexes that drive cellular energy production. It is an organosulfur compound that is synthesized naturally but is also produced synthetically to create the high-quality active ingredient used in pharmaceutical preparations. Its role in cellular defense is considered a foundational substance for metabolic health.

Forms, Composition, and General Role of Thioctic Acid

The pharmaceutical product, containing Thioctic acid, is available for both oral and parenteral administration, typically formulated as a tablet or capsule for oral intake and as a sterile solution for injection for intravenous use. Thioctic acid functions as a highly effective antioxidant capable of acting across both water-soluble and lipid-soluble cellular environments, which distinguishes it from antioxidants that are restricted to one domain. It has the potential to support healthy nerve function by mitigating oxidative stress, helping to protect sensitive tissues. Its primary general purpose is to provide widespread protection against oxidative stress and to support cellular health, thereby aiding the maintenance of overall metabolic balance.

What side effects are possible with Lipoic acid?

Possible Side Effects and Safety Information

The safety profile for Thioctic acid (Lipoic acid) is established through regulatory classifications that document adverse reactions by frequency and affected body systems. This information is derived from official governmental sources, such as the FDA and European regulatory agencies, and focuses on documented risks rather than instructional guidance.


Adverse Reaction Frequencies and System Classes

The officially listed adverse reactions are categorized across several System-Organ Classes:

  • Immune System Disorders: Including allergic reactions and, rarely, systemic allergic reactions up to Anaphylactic shock.
  • Metabolism and Nutrition Disorders: Involving the risk of hypoglycaemia-like symptoms.
  • Nervous System Disorders: Reactions documented as Very Rare include disturbances to the sense of taste and convulsions.
  • Skin and Subcutaneous Tissue Disorders: Encompassing general allergic skin reactions, such as urticaria, itching, and rash.
Frequency Classification Examples of Reactions
Very Rare Disturbances to sense of taste, Convulsion, Double vision
Frequency Unknown Insulin Autoimmune Syndrome (IAS), Systemic allergic reactions, Hypoglycaemia-like symptoms

Serious Safety Considerations and Constraints

Specific serious adverse events are highlighted in the regulatory documentation. These include the risk of Anaphylactic shock and Insulin Autoimmune Syndrome (IAS), the latter being a rare, sometimes lethal, autoimmune reaction that causes severe hypoglycaemia.

A crucial safety constraint is the substance's effect on glucose metabolism: Thioctic acid may reinforce the blood-sugar lowering effect of co-administered insulin or oral anti-diabetic agents. Due to this effect on glucose utilisation, the possibility of developing symptoms similar to a low blood sugar event is a specific safety note.

Regulatory documents also state that individuals with certain human leukocyte antigen (HLA) genotypes have an increased susceptibility to developing IAS, a consideration noted for specific populations.

Overdose and Emergency Response

For any suspicion of significant overdose with Lipoic acid (Thioctic acid), official regulatory guidance mandates to go promptly and seek transportation to the hospital. This immediate action is necessary because overdose is documented as potentially causing serious, sometimes lethal, systemic toxicity.

Overdose may initially present with clinical manifestations such as nausea, vomiting, and headache. Severe outcomes reported in regulatory documents involve multiple physiological systems and include:

  • Neurological: Seizures with loss of consciousness and neurologic effects.
  • Metabolic/Systemic: Acid-base disturbances (lactic acidosis), hypoglycemia, and shock.
  • Hematologic: Serious disturbances of blood clotting (coagulopathy) and hemolysis.
  • Muscular/Organ: Rhabdomyolysis (damage of the muscles) and multiple organ dysfunction.

The official documentation notes that no specific antidote is known, and therefore treatment is administered according to the general treatment principles for cases of poisoning (symptomatic and supportive treatment). Close monitoring is necessary for exposed children, and is advised for patients with existing psychological issues. Severe poisoning has been specifically noted when doses greater than 10 grams were used alongside excessive alcohol consumption.

Therapeutic Uses of Lipoic acid

The primary therapeutic use of Lipoic acid (Thioctic acid) centers on its ability to support nerve health in conditions marked by chronic metabolic damage. Lipoic acid is commonly used to help with managing chronic diseases characterized by symptoms related to systemic imbalance, most notably diabetic neuropathy. This agent is most commonly applied in patients with diabetic peripheral neuropathy (DPN) to address the persistent and disruptive sensory symptoms.

It is relevant for easing symptoms related to physical discomfort, which primarily include burning pain, tingling (paresthesias), and chronic numbness felt in the extremities. This application is often used in a supportive approach, where assistance is commonly used to help with managing the overall burden of symptoms. Lipoic acid is considered relevant in clinical settings where chronic metabolic disturbances lead to increased physiological strain. It is utilized as a supportive therapeutic agent to support nerve function in conditions involving chronic metabolic disturbances, thereby contributing to easing the overall symptom load for patients managing chronic conditions.

“The benefit provided supports general well-being during symptomatic phases.”


Quick Fact: Relief for Neuropathic Symptoms Lipoic acid is applied when managing the sensory manifestations of diabetic peripheral neuropathy, focusing on easing symptoms like burning, numbness, and tingling that create noticeable physiological strain.

Regulatory References

  1. NCBI StatPearls overview

Eligibility and Restrictions for Use

This section outlines the official population eligibility and exclusion criteria for Lipoic acid (Thioctic acid), as defined by regulatory health authorities.

Eligibility Scope

Category Official Regulatory Status
Populations Allowed Adult patients (generally mathbf18 years and older) without documented contraindications.
Populations Contraindicated Patients with known hypersensitivity to the active substance, Thioctic acid, or to any of the specific excipients in the product.
Age-Related Eligibility Children and adolescents (under mathbf18 years of age) are not recommended; safety and efficacy have not been established.
Pregnancy/Lactation Status Not recommended due to a lack of sufficient and reliable human data to confirm safety for the fetus or infant.

Eligibility-Related Restrictions

  • Conditional Use: Patients with diabetes or thyroid disorders must use the medicine with caution and require monitoring due to its documented effect on blood sugar and thyroid hormone levels.
  • Organ Impairment: Use in renal impairment typically requires no dose adjustment as pharmacokinetics are generally unaffected.

Connection to the Overall Eligibility Profile

Regulatory documents define eligibility by mandating exclusion based on hypersensitivity and implementing restrictions for populations where safety data is insufficient, primarily children and women who are pregnant or breastfeeding. Conditional use statements focus on underlying metabolic disorders where the medicine's properties require medical oversight.

What should I know about interactions with other medicines?

The official regulatory profile for Lipoic acid (Thioctic acid) documents several clinically significant interaction patterns with medicinal products and specific substances.

Drug–Drug Interactions

Co-administration with Insulin and Oral Antidiabetic Agents may potentiate their glucose-lowering effects. This documented pharmacodynamic enhancement results in an officially stated increased risk of hypoglycemia. Regulatory information advises special consideration for individuals already susceptible to low blood sugar, such as those with malnutrition or defective counterregulatory mechanisms. Separately, Lipoic acid may reduce the intended therapeutic effect of Thyroid Hormone replacement therapy. The product's activity may also decrease the cytotoxic efficacy of Platinum-containing Chemotherapeutics, such as Cisplatin.


Timing and Absorption Requirements

Lipoic acid is subject to an absorption interference interaction with Iron Salts and other Ferric Compounds. This binding reduces the oral absorption and subsequent systemic exposure of Lipoic acid. To mitigate this effect, official prescribing information mandates a separation of administration timing between Lipoic acid and these metal compounds.


Substance Interactions

The combined use of Lipoic acid with Alcohol or Herbal Products known to lower blood sugar is noted to further increase the documented risk of hypoglycemia, particularly in the context of antidiabetic treatment. This establishes a key interaction constraint related to dietary and lifestyle substances, based on regulatory guidance.

Mechanism of Action

️ Dual-Phase Antioxidant and Redox Support

Lipoic acid (Thioctic acid) operates as a dual-soluble scavenger of Reactive Oxygen Species (ROS), active in both the aqueous and fatty environments of the cell. Its ability lies in the LA/DHLA redox cycle, which enables it to directly neutralize free radicals and regenerate exhausted endogenous antioxidants like Glutathione and Vitamin E. The mechanism provides a sustained reduction of reactive oxygen species, with the effects of this mechanism observed at the level of tissue structure and function.


Metabolic Cofactor and Insulin Pathway Modulation

The molecule is an essential cofactor for two key mitochondrial enzyme complexes, Pyruvate Dehydrogenase and alpha-Ketoglutarate Dehydrogenase, both necessary for cellular ATP synthesis and energy metabolism. Additionally, it acts as a signaling modulator by inhibiting the enzyme Protein Tyrosine Phosphatase 1B (PTP1B). This inhibition facilitates increased glucose uptake and utilization by cells and results in modulation of metabolic signaling.


Anti-inflammatory Transcriptional Control

Lipoic acid influences gene expression related to inflammatory responses. It functions as an inhibitor of I Kappa B Kinase (IKK), which prevents the activation and nuclear migration of the pro-inflammatory transcription factor NF-kappaB. This intervention restricts the transcription of pro-inflammatory mediators, thereby modulating the local tissue response via signaling pathways.

Dosage and Administration Information

How to Use Lipoic Acid

Lipoic acid (Thioctic acid) is used according to a standardized, two-phase protocol primarily for the management of symptomatic diabetic polyneuropathy. The therapeutic regimen is structured by a short, intensive intravenous (IV) course followed by long-term oral maintenance.


Official Administration Protocol

Administration Phase Route and Frequency Dosing Schedule Key Procedural Requirement
Initial (Acute) Intravenous (IV) Infusion, Once Daily 600 mg daily Administered slowly over a minimum of 30 minutes
Maintenance Oral (Tablet or Capsule), Once Daily 600 mg daily Taken preferably on an empty stomach

Use Pattern and Duration

The initial IV phase typically lasts for 2 to 4 weeks to stabilize symptoms. Following this acute course, the treatment transitions to the oral route with the same daily dose for a long-term continuation strategy, as the underlying condition is chronic.

Preparation and Handling

The solution for infusion must be protected from light (e.g., using a light-protection bag) to maintain the stability of the active substance, and the infusion should commence immediately after the vial is opened. The medicine is not recommended for use in children and adolescents, as there is insufficient clinical experience for these age groups. These instructions define a clear procedural structure for the clinical application of Lipoic acid.

Recent Clinical Evidence

Research evidence / Overview of studies for Lipoic acid

Evidence for use in Diabetic Peripheral Neuropathy

Lipoic acid (Thioctic acid) was evaluated in research exploring conditions characterized by chronic metabolic damage, most notably Diabetic Peripheral Neuropathy (DPN). Research was conducted in adult populations with Type 1 or Type 2 Diabetes, often including participants experiencing perceptible sensory symptoms.

The primary method used to evaluate this compound's study context is through Randomized Controlled Trials (RCTs), with findings consolidated in Systematic Reviews and Meta-analyses. These designs were used in research exploring how symptoms change over time, monitoring outcomes related to symptom variability, particularly positive neuropathic symptoms like burning pain, tingling, and chronic numbness. Other research monitored physiological strain by examining measures of nerve health, such as nerve conduction velocity (NCV), and assessed neurological functional impairment.

Long-Term Studies and Durability of Follow-up

Research has examined Lipoic acid over various time intervals, with follow-up durations extending in some large trials up to four years. Studies observed responses over defined time intervals, monitoring measures of nerve function and impairment. However, high-level evidence syntheses often note that comprehensive data showing the durability of any observed patterns beyond intermediate periods, such as six months, are still emerging. Therefore, research has not fully established long-term patterns related to the evolution of neuropathy progression in the scientific literature.

Research Gaps and Areas of Uncertainty

The overall evidence base for Lipoic acid contributes to understanding symptom patterns, but it also highlights areas where certainty remains low. A recurring limitation noted by review authors is the evidence quality varies across studies. Several trials included in systematic reviews were judged to have a high risk of attrition bias, meaning a significant number of participants dropped out before the study was completed, which can influence the final reported findings.

Furthermore, comparative evidence is lacking for Lipoic acid's effect on certain long-term, critical outcomes linked to functional imbalance. The evidence has not yet determined long-term patterns related to DPN complications such as foot ulceration or amputation. Research is ongoing to address these gaps and further contextualize how patients reported their experience during varying symptom burdens.

Frequently Asked Questions (FAQ)

Common questions about Lipoic acid (FAQ)

Q: Why is Lipoic acid sometimes referred to as a 'universal antioxidant'?

Lipoic acid is characterized by its solubility in both water and fat, unlike some other antioxidants. This dual solubility is noted to support the compound's activity across both the aqueous and fatty environments within the cell and throughout the body. Official descriptions note this dual solubility is the basis for it sometimes being referred to as a universal antioxidant.

Q: What is the difference between R-Lipoic acid and S-Lipoic acid?

The Lipoic acid molecule is composed of two different forms, known as the R-form and the S-form. The R-form is the version that occurs naturally within the human body and functions as an important metabolic cofactor. Pharmaceutical products may contain the natural R-form or a racemic mixture that includes both the R- and S-forms.

Q: How long does it typically take for Lipoic acid to start working?

The initial, intensive intravenous course is typically administered for 2 to 4 weeks to help address symptoms of diabetic polyneuropathy. According to summaries of clinical studies, several weeks of continuous treatment were often observed for the intended response to emerge.

Q: Can Lipoic acid affect the absorption of other nutrients?

Official prescribing information specifically indicates that Lipoic acid can interfere with the oral absorption of Iron Salts and other ferric (iron-containing) compounds. To mitigate this effect, official guidance specifies that separation in administration timing is necessary.

Q: Does Lipoic acid have a maximum recommended period for continuous use?

The oral phase of Lipoic acid treatment is designated as a long-term continuation strategy for chronic conditions. Research summaries indicate that clinical studies have examined the use of Lipoic acid over periods extending up to four years, where the treatment was reported to be well tolerated at standard doses.

Q: Can Lipoic acid be taken with other common antioxidants like Vitamin C or E?

Lipoic acid has a unique role in the body's redox system, meaning it helps balance the effects of oxidation. Its mechanism of action includes the ability to help regenerate exhausted endogenous antioxidants such as Glutathione and Vitamin E that are naturally present in the body.

Q: Are there specific over-the-counter supplements that should be avoided with Lipoic acid?

Regulatory information notes interactions with certain herbal products known to lower blood sugar, which can increase the risk of low blood sugar events. Additionally, taking Lipoic acid at the same time as Iron Salts or other ferric compounds is noted to interfere with Lipoic acid’s absorption.

Q: Are there foods that contain Lipoic acid naturally?

Lipoic acid is an endogenous substance, meaning it is synthesized naturally within the body, but it is also found in various foods. Natural dietary sources are described in health resources as including red meats, organ meats, broccoli, and spinach.

Q: Is heartburn or stomach upset a common problem when taking Lipoic acid?

Gastrointestinal symptoms are among the side effects that have been frequently reported in clinical use. These documented reactions include nausea, vomiting, abdominal discomfort, and heartburn.

Q: Can Lipoic acid cause a headache or lightheadedness?

Official safety information reports that symptoms such as a headache or a light-headed feeling have been documented. These symptoms have been noted in connection with the risk of low blood sugar events, which is a known safety consideration with Lipoic acid use due to its effect on glucose utilization.

Q: What should be done if a skin rash develops after starting Lipoic acid?

Official safety information advises that signs of a generalized allergic reaction, including skin rash, can occur. In the event of such a reaction, official regulatory information notes that such events may require immediate cessation of use and professional attention.

Q: Can Lipoic acid affect the color or smell of urine?

Some patient safety information reports that the active substance can lead to a noticeable sulfur-like odor in the urine as the body processes the compound. This effect is related to the chemical nature of Lipoic acid and is generally described as harmless.

Q: What are the general signs of taking too much Lipoic acid?

In cases of single large overdoses, official toxicology reports have documented several severe symptoms. These include states such as confusion, stupor, and seizures, with the risk of severe complications like multiorgan failure.

Q: Are there any liver-related concerns with using Lipoic acid?

While Lipoic acid is generally not associated with liver injury in standard therapeutic use, some safety reports have noted a potential for liver mitochondrial damage. This concern has been documented primarily when the substance is administered above the standard intravenous doses.

Q: Is Lipoic acid use a concern for people who are Thiamine deficient?

Thiamine (Vitamin B1) is an essential nutrient required for the body to properly utilize Lipoic acid. Official prescribing precautions advise that individuals with a known or suspected state of Thiamine deficiency is an official precaution that may require close monitoring during treatment.

Q: Has Lipoic acid been studied for its effect on blood pressure?

Official safety information documents that hypotension (low blood pressure) has been reported as an occasional adverse effect. This effect may occur during the use of Lipoic acid.

How should Lipoic acid be stored and disposed of?

How to Store and Dispose of Lipoic acid?

Lipoic acid has specific requirements to maintain its stability and effectiveness, primarily due to its sensitivity to light, moisture, and air. Official regulatory information outlines the following strict handling and storage conditions:

  • Storage Temperature: Keep refrigerated, typically between 2 °C and 8 °C.
  • Protection: The product is sensitive, so it must be protected from light and moisture. Containers should be kept tightly closed in a dry, cool place.
  • Handling: Keep out of the reach of children. When handling bulk material, avoid dust formation and use in a well-ventilated area.
  • Disposal: Do not dispose of this medication by flushing it down a toilet or pouring it into a drain unless instructed otherwise. It is classified as toxic to aquatic life and should not be released into the environment. Dispose of the contents and container according to local and national regulations for hazardous or controlled waste, typically through an approved disposal facility.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lipoic acid found in:

A-Z Index: